Organization | Fisons

Fisons Report issue

Contributed to NME For profit

Founded: Thetford United Kingdom (1843)

Status: Acquired by Rhone-Poulenc Rorer (1995) → now Sanofi-Aventis (2004)

Organization Overview

First Clinical Trial

1999

NCT00002053

First Marketed Drug

1980

aminophylline (aminophyllin)

First NDA Approval

1992

nedocromil (tilade)

Last Known Activity

1999

Timeline

NOW

Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

FISONS

Active Ingredients

Marketed Drugs (11)

aminophylline (aminophyllin)

amphetamine (Adderall)

chlorpheniramine (ChlorTrimeton) (1986)

codeine (Phenergan) (1986)

cromoglicic acid (Intal) (NDA)

dexchlorpheniramine maleate (polaramine) (1986)

metolazone (zaroxolyn) (NDA)

nedocromil (tilade) (1992 NDA)

pseudoephedrine (Benylin) (1986)

theophylline (synophylate)

Drugs in Other Trials (1)

pentamidine (pentam) (5 trials)

Indications

Approved Indications

Conjunctivitis, Allergic

Rhinitis, Allergic, Seasonal

Overview

Highest Phase: Phase 0
# of Trials: 5
# of Trial APIs: 1